A new line immunoassay for the multiparametric detection of antiganglioside autoantibodies in patients with autoimmune peripheral neuropathies

Annals of the New York Academy of Sciences

Volumn 1109, Issue , 2007, Pages 256-264

  Conrad, Karsten ^a   Schneider, Hauke ^b   Ziemssen, Tjalf ^b   Talaska, Thomas ^c   Reinhold, Dirk ^d   Humbel, Rene Louis ^e   Roggenbuck, Dirk ^f  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^c Regional Consiliary Center for Tick borne Diseases   (Germany)

^d OTTO VON GUERICKE UNIVERSITY   (Germany)

^e Laboratoire Luxembougeois d'Immuno Pathologie   (Luxembourg)

^f GA GENERIC ASSAYS GMBH   (Germany)

Author keywords

Autoantibodies; Autoimmune peripheral neuropathies; Ganglioside; Line immunoassay

Indexed keywords

GANGLIOSIDE ANTIBODY; GANGLIOSIDE GD 1A; GANGLIOSIDE GD 1B; GANGLIOSIDE GD2; GANGLIOSIDE GD3; GANGLIOSIDE GM1; GANGLIOSIDE GM2; GANGLIOSIDE GM3; GANGLIOSIDE GM4; GANGLIOSIDE GQ 1B; GANGLIOSIDE GT 1B; UNCLASSIFIED DRUG; AUTOANTIBODY; GANGLIOSIDE;

ANTIBODY DETECTION; AUTOIMMUNE DISEASE; BLOOD DONOR; CONFERENCE PAPER; CONTROLLED STUDY; GUILLAIN BARRE SYNDROME; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; MOTOR NEUROPATHY; PERIPHERAL NEUROPATHY; SYSTEMIC LUPUS ERYTHEMATOSUS; ARTICLE; BLOOD; IMMUNOLOGY; METHODOLOGY; SENSITIVITY AND SPECIFICITY;

AUTOANTIBODIES; AUTOIMMUNE DISEASES; GANGLIOSIDES; HUMANS; IMMUNOASSAY; PERIPHERAL NERVOUS SYSTEM DISEASES; SENSITIVITY AND SPECIFICITY;

EID: 34848819483     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1398.031     Document Type: Conference Paper

References (16)

1. HADDEN, R.D.M., H. KARCH, H.-P. HARTUNG, et al. 2001. Preceding infections, immune factors, and outcome in Guillain-Barré syndrome. Neurology 56: 758-765.
2. WILLISON, H.J. & N. YUKI. 2002. Peripheral neuropathies and anti-glycolipid antibodies. Brain 125: 2591-2625.
3. HADDEN, R.D.M., D.R. CORNBLATH, R.A. HUGHES, et al. 1998. Electrophysiological classification of Guillain-Barré syndrome: clinical associations an outcome. Ann. Neurol. 44: 780-788.
4. SANDER, W. & N. LATOV. 2003. Research criteria for defining patients with CIDP. Neurology 60(Suppl): S8-S15.
5. HUGHES, R.A.C. & D.R. CORNBLATH. 2005. Guillain-Barré syndrome. Lancet 336: 1653-1666.
6. ILYAS, A.A., H.J. WILLISON, R.H. QUARLES, et al. 1988. Serum antibodies to gangliosides in Guillain-Barré syndrome. Ann. Neurol. 23: 440-447.
7. BUCHARD, C., C. LACROIX, V. PLANTE, et al. 1999. Clinicopathologic findings and prognosis of chronic inflammatory demyelinating polyneuropathy. Neurology 52: 498-503.
8. LEGER, J.-M. & A. BEHIN. 2005. Multifocal motor neuropathy. Curr. Opin. Neurol. 18: 567-573.
9. SHEIKH, K.A., T.J. DEERINCK, M.H. ELLISMAN, et al. 1999. The distribution of ganglioside-like moieties in peripheral nerves. Brain 122: 449-460.
10. GONG, Y., Y. TAGAWA, M.P. LUNN, et al. 2002. Localization of major gangliosides for immune neuropathies. Brain 125: 2491-2506.
11. AD HOC NINCDS COMMITTEE. 1978. Criteria for the diagnosis of Guillain-Barré syndrome. Ann. Neurol. 3: 565-566.
12. OLNEY, R.K., R.A. LEWIS, T.D. PUTNAM, et al. 2003. Consensus criteria for the diagnosis of multifocal motor neuropathy. Muscle Nerve 27: 117-121.
13. TAN, E.M., A.S. COHEN, J.F. FRIES, et al. 1982. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 25: 1271-1277.
14. WILLISON, H.J. 2007. Ganglioside autoantibodies. In Autoantibodies. Y. Shoenfeld, M.E. Gershwin & P.L. Meroni, Eds.: 611-618. Elsevier. Amsterdam.
15. PESTRONK, A., V. CHAUDRY, E.L. FELDMAN, et al. 1990. Lower neuron syndromes defined by patterns of weakness, nerve conduction abnormalities, and high titres of antiglycolipid antibodies. Ann. Neurol. 27: 316-326.
16. KIESEIER, B.C., R. KIEFER, R. GOLD, et al. 2004. Advances in understanding and treatment of immune-mediated disorders of the peripheral nervous system. Muscle Nerve 30: 131-156.